Anthony Caggiano - 03 Feb 2023 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role: Chief Medical Officer
Signature: /s/ Anthony Caggiano
Issuer symbol: CGTX
Transactions as of: 03 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 07 Feb 2023, 15:05:40 UTC
Previous filing: 25 Mar 2022
Next filing: 09 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CGTX	Common Stock	Award	$0	+94,406		$0.000000	94,406	03 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CGTX	Stock Option (Right to Buy)	Award	$0	+94,406		$0.000000	94,406	03 Feb 2023	Common Stock	94,406	$2.12	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
F2	The option vests 33.3% on February 3, 2024, with the remaining 66.7% vesting in 24 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates.